CYCLERION THERAPEUTICS, INC. (KRSA) Operating income 2018–2025
CYCLERION THERAPEUTICS, INC. (KRSA) annual operating income history from SEC filings — each fiscal year as reported.
-$5.0MFY2025 · since FY2018: -$115.3M → -$5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.0M | -37.1% |
| FY2024 | -$3.6M | +72.0% |
| FY2023 | -$13.0M | +30.1% |
| FY2022 | -$18.5M | +66.4% |
| FY2021 | -$55.2M | +32.1% |
| FY2020 | -$81.3M | +35.0% |
| FY2019 | -$125.0M | -8.5% |
| FY2018 | -$115.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating marginKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →